C. Vallvé

发表

Complexity of the genetic contribution to factor VII deficiency in two Spanish families: clinical and biological implications.

J. Fontcuberta, M. Sabater-Lleal, J. Soria, 2003, Haematologica.

PERITONEAL DIALYSIS IN ARGENTINA. A NATIONWIDE STUDY

J. Lobo, C. Vallvé, J. Schargorodsky, 2011, Peritoneal Dialysis International.

Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.

J. Fontcuberta, J. Souto, J. Soria, 2001, Haematologica.

Thromboplastin-thrombomodulin-mediated time: a new global test sensitive to protein S deficiency and increased levels of factors II, V, VII and X.

J. Fontcuberta, J. Mateo, M. Borrell, 2002, Haematologica.

The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism

J. Fontcuberta, J. Soria, J. Mateo, 2005, Thrombosis and Haemostasis.

Platelet hyperaggregability and venous thrombosis risk: results from the RETROVE project.

J. Fontcuberta, J. Souto, J. Mateo, 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

VAMP8 and serotonin transporter levels are associated with venous thrombosis risk in a Spanish female population. Results from the RETROVE Project.

J. Fontcuberta, J. Souto, J. Mateo, 2019, Thrombosis research.

A boy with venous thrombosis, homozygous for factor V Leiden, prothrombin G20210A and MTHFR C667t mutations, but belonging to an asymptomatic family.

J. Fontcuberta, J. Soria, C. Vallvé, 2000, Haematologica.

Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter A double-blind, randomized, placebo-controlled trial

M. Vilardell, M. Bleda, C. Vallvé, 1999, European Journal of Clinical Pharmacology.

Low ADAMTS13 levels are associated with venous thrombosis risk in women.

J. Fontcuberta, J. Souto, J. Mateo, 2017, Thrombosis research.

Low levels of tissue factor pathway inhibitor (TFPI) in two out of three members of a family with thrombophilia.

J. Fontcuberta, J. Mateo, M. Borrell, 1995, Thrombosis research.

Nosocomial pneumonia: Comparative multicentre trial between monotherapy with cefotaxime and treatment with antibiotic combinations

C. Arnau, F. Gudiol, M. Fernández-Guerrero, 2005, Infection.

Clobazam: Single or divided doses?

C. Arnau, C. Vallvé, C. Piña, 2004, European Journal of Clinical Pharmacology.

An acquired inhibitor that produced a delay of fibrinopeptide B release in an asymptomatic patient.

J. Fontcuberta, M. Borrell, R. Felices, 2007, Haematologica.

What is the clinical impact of low plasminogen activator inhibitor‐1 (PAI‐1) activity? A case report and study of the incidence of low PAI‐1 antigen in a healthy population

J. Fontcuberta, J. Mateo, A. Santamaría, 2007, Journal of thrombosis and haemostasis : JTH.

Antibiotic prophylaxis with cefotaxime in gastroduodenal and biliary surgery.

C. Arnau, J A Garcia-Rodriguez, C. Vallvé, 1989, American journal of surgery.

The influence of low protein S plasma levels in young women, on the definition of normal range.

J. Fontcuberta, M. Borrell, C. Vallvé, 1994, Thrombosis research.